Oncology Today with Dr Neil Love cover image

Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review

Oncology Today with Dr Neil Love

00:00

YAHIT‑3: Yonalimab in Refractory ITP

Hanny summarizes YAHIT-3 single-arm results: 44% response, ~24% six‑month durable responses, and reduced bleeding after four infusions.

Play episode from 08:15
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
 Get the app